Safety of lymphocytes immunotherapy during the COVID-19 outbreak in Wuhan, China

Detalles Bibliográficos
Autores principales: Chang, Tianli, Song, Su, Huang, Donghui, Su, Ping, Xiao, Xianjin, Li, Honggang, Liao, Aihua, Xiang, Wenpei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778486/
https://www.ncbi.nlm.nih.gov/pubmed/33389097
http://dx.doi.org/10.1007/s00404-020-05829-3
_version_ 1783631136420790272
author Chang, Tianli
Song, Su
Huang, Donghui
Su, Ping
Xiao, Xianjin
Li, Honggang
Liao, Aihua
Xiang, Wenpei
author_facet Chang, Tianli
Song, Su
Huang, Donghui
Su, Ping
Xiao, Xianjin
Li, Honggang
Liao, Aihua
Xiang, Wenpei
author_sort Chang, Tianli
collection PubMed
description
format Online
Article
Text
id pubmed-7778486
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-77784862021-01-04 Safety of lymphocytes immunotherapy during the COVID-19 outbreak in Wuhan, China Chang, Tianli Song, Su Huang, Donghui Su, Ping Xiao, Xianjin Li, Honggang Liao, Aihua Xiang, Wenpei Arch Gynecol Obstet Correspondence Springer Berlin Heidelberg 2021-01-02 2021 /pmc/articles/PMC7778486/ /pubmed/33389097 http://dx.doi.org/10.1007/s00404-020-05829-3 Text en © Springer-Verlag GmbH Germany, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Correspondence
Chang, Tianli
Song, Su
Huang, Donghui
Su, Ping
Xiao, Xianjin
Li, Honggang
Liao, Aihua
Xiang, Wenpei
Safety of lymphocytes immunotherapy during the COVID-19 outbreak in Wuhan, China
title Safety of lymphocytes immunotherapy during the COVID-19 outbreak in Wuhan, China
title_full Safety of lymphocytes immunotherapy during the COVID-19 outbreak in Wuhan, China
title_fullStr Safety of lymphocytes immunotherapy during the COVID-19 outbreak in Wuhan, China
title_full_unstemmed Safety of lymphocytes immunotherapy during the COVID-19 outbreak in Wuhan, China
title_short Safety of lymphocytes immunotherapy during the COVID-19 outbreak in Wuhan, China
title_sort safety of lymphocytes immunotherapy during the covid-19 outbreak in wuhan, china
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778486/
https://www.ncbi.nlm.nih.gov/pubmed/33389097
http://dx.doi.org/10.1007/s00404-020-05829-3
work_keys_str_mv AT changtianli safetyoflymphocytesimmunotherapyduringthecovid19outbreakinwuhanchina
AT songsu safetyoflymphocytesimmunotherapyduringthecovid19outbreakinwuhanchina
AT huangdonghui safetyoflymphocytesimmunotherapyduringthecovid19outbreakinwuhanchina
AT suping safetyoflymphocytesimmunotherapyduringthecovid19outbreakinwuhanchina
AT xiaoxianjin safetyoflymphocytesimmunotherapyduringthecovid19outbreakinwuhanchina
AT lihonggang safetyoflymphocytesimmunotherapyduringthecovid19outbreakinwuhanchina
AT liaoaihua safetyoflymphocytesimmunotherapyduringthecovid19outbreakinwuhanchina
AT xiangwenpei safetyoflymphocytesimmunotherapyduringthecovid19outbreakinwuhanchina

Ejemplares similares